{"ok":true,"article":{"slug":"the-rationale-for-jak-inhibition-pd-1-blockade-in-immune-resistant-rcc-1f727bec","title":"The Rationale for JAK Inhibition/PD-1 Blockade in Immune-Resistant RCC","url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTno4bVMxN3NhcjB6NkV4Q0E4STE5b3ZhazF5NkFDWWdOWlJQc2ZHaWZQMkozcENSMzZTV0F6WkhCZWk2VzZYUzJHRnRKczNHZFAyZEJyaHlnWHd2bHR4bWFDdzVMYUlvOWtSTnEwMC1uTjR3YlBsa25aUWNzSnBKZUo1cm9oZEZiRktZdC0tY2pvcTd3V2hBdG96dVFQaTZXN0hNX0lodnU?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/the-rationale-for-jak-inhibition-pd-1-blockade-in-immune-resistant-rcc-1f727bec","sourceName":"CancerNetwork","summary":"Related coverage: The Rationale for JAK Inhibition/PD-1 Blockade in Immune-Resistant RCC CancerNetwork","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-15T14:03:45+00:00","createdAt":"2026-08-15T14:30:13.763397+00:00"}}